MedPAC Urged by AHA to Scrutinize MA Impacts on Hospital and Post-Acute Provider Finances

Why It Matters

MA’s expanding footprint could strain hospital cash flows and increase Medicare spending, prompting policymakers to reassess payment structures. Understanding these dynamics is critical for preserving provider viability and controlling federal health‑care costs.

Key Takeaways

• AHA asks MedPAC to study Medicare Advantage’s financial impact on hospitals
• MA enrollment adds administrative burdens beyond Traditional Medicare
• AHA submitted written comments to MedPAC in Oct 2025 and Jan 2026
• Potential cost growth for Medicare program flagged by AHA

Pulse Analysis

Medicare Advantage has become a dominant enrollment option, now covering roughly half of Medicare beneficiaries. While MA promises coordinated care and supplemental benefits, its payment model shifts risk to private insurers, leaving hospitals and post‑acute facilities to navigate a complex web of contracts and reporting requirements. The American Hospital Association argues that these requirements are not only more onerous than those under Traditional Medicare but also financially unsustainable for many providers, especially smaller community hospitals that rely heavily on Medicare revenue.

The AHA’s push for MedPAC scrutiny reflects growing anxiety over the fiscal health of the acute and post‑acute care continuum. Administrative tasks such as dual billing, prior authorizations, and data submissions consume staff time and increase overhead, diverting resources from patient care. Moreover, the commission’s recent focus on payment incentives underscores a broader policy debate: whether MA’s cost growth—driven by higher negotiated rates and supplemental services—will outpace the savings it purports to generate for the Medicare program. By flagging these concerns, the AHA hopes to trigger reforms that align MA incentives with provider sustainability.

If MedPAC acts on the AHA’s recommendations, future policy could involve tighter oversight of MA contracts, standardized reporting protocols, or adjustments to reimbursement formulas that better reflect the true cost of care delivery. Such changes would aim to protect hospital margins while ensuring beneficiaries retain access to high‑quality services. Stakeholders across the health‑care ecosystem will be watching closely, as any shift in MA regulation could reshape payment flows, influence market competition, and ultimately impact the overall trajectory of Medicare spending.